Mayo Investment Advisers LLC held its stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 3,500 shares of the healthcare conglomerate’s stock at the close of the 2nd quarter. Mayo Investment Advisers LLC’s holdings in UnitedHealth Group were worth $649,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the stock. State Street Corp increased its position in shares of UnitedHealth Group by 2.5% during the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock valued at $7,499,276,000 after acquiring an additional 1,122,534 shares during the last quarter. Veritas Asset Management LLP increased its position in shares of UnitedHealth Group by 8.2% during the second quarter. Veritas Asset Management LLP now owns 5,291,867 shares of the healthcare conglomerate’s stock valued at $981,218,000 after acquiring an additional 399,878 shares during the last quarter. Legal & General Group Plc increased its position in shares of UnitedHealth Group by 2.6% during the second quarter. Legal & General Group Plc now owns 5,085,698 shares of the healthcare conglomerate’s stock valued at $943,004,000 after acquiring an additional 131,006 shares during the last quarter. American Century Companies Inc. increased its position in shares of UnitedHealth Group by 16.9% during the second quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after acquiring an additional 681,111 shares during the last quarter. Finally, Harris Associates L P increased its position in shares of UnitedHealth Group by 0.3% during the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock valued at $762,041,000 after acquiring an additional 14,489 shares during the last quarter. 86.17% of the stock is owned by institutional investors.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of UnitedHealth Group stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. Insiders have sold 72,149 shares of company stock valued at $14,212,342 in the last three months. 0.89% of the stock is owned by corporate insiders.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.07 on Monday. The stock has a market capitalization of $204,080.00, a price-to-earnings ratio of 21.99, a P/E/G ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 52 week low of $146.01 and a 52 week high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.72 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $2.17 earnings per share. equities analysts expect that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.42%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is 34.09%.

A number of analysts recently commented on the company. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Credit Suisse Group initiated coverage on UnitedHealth Group in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 target price for the company. Mizuho reissued a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, October 24th. Oppenheimer Holdings, Inc. raised their target price on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $219.00 target price (up from $210.00) on shares of UnitedHealth Group in a research report on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $216.65.

TRADEMARK VIOLATION NOTICE: “Mayo Investment Advisers LLC Continues to Hold Stake in UnitedHealth Group Incorporated (UNH)” was posted by Daily Political and is the property of of Daily Political. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/11/13/mayo-investment-advisers-llc-continues-to-hold-stake-in-unitedhealth-group-incorporated-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.